Global Medical Probiotics Market Insights and Forecast to 2028

Medical probiotics are live micro-organisms which, when administrated in adequate amounts, confer a health benefit on the host. While the traditional delivery vehicle for probiotics was fresh dairy products, they are now found in many varieties of dietary supplements and healthcare products.
Market Analysis and Insights: Global Medical Probiotics Market
Due to the COVID-19 pandemic, the global Medical Probiotics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Bifidobacterium accounting for % of the Medical Probiotics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
China Medical Probiotics market size is valued at US$ million in 2021, while the US and Europe Medical Probiotics are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical Probiotics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Medical Probiotics include DowDuPont, Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Novozymes, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Medical Probiotics Scope and Segment
Medical Probiotics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Probiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bifidobacterium
Lactobacillus
Others
Segment by Application
Pharmaceuticals
Dietary Supplements
Others
By Company
DowDuPont
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Novozymes
DSM
Ganeden
Glory Biotech
Unique Biotech
Winclove Probiotics
UAS Laboratories
Synbiotech
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Frequently Asked Questions